(Q44890057)

7 December 2017

Characterization of risk for general population exposure to perfluorooctanoate (English)

1 reference

7 December 2017

John L Butenhoff

1

1 reference

7 December 2017

David W Gaylor

2

1 reference

7 December 2017

John A Moore

3

1 reference

7 December 2017

Geary W Olsen

4

1 reference

7 December 2017

Joseph Rodricks

5

1 reference

7 December 2017

Jeffrey H Mandel

6

1 reference

7 December 2017

Larry R Zobel

7

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

Regulatory Toxicology and Pharmacology

7 December 2017

1 reference

7 December 2017

39

1 reference

7 December 2017

3

1 reference

7 December 2017

363-380

1 reference

Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis

7 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Hepatic peroxisome proliferation in rodents and its significance for humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Perfluorooctanoate, perflourooctanesulfonate, and N-ethyl perfluorooctanesulfonamido ethanol; peroxisome proliferation and mitochondrial biogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Effects of Ammonium Perfluorooctanoate on Leydig-Cell Function: In Vitro, in Vivo, and ex Vivo Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Gender-specific and developmental influences on the expression of rat organic anion transporters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Leydig cell hyperplasia and adenoma formation: mechanisms and relevance to humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Induction of Leydig cell adenomas by ammonium perfluorooctanoate: a possible endocrine-related mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Rodent Leydig cell tumorigenesis: a review of the physiology, pathology, mechanisms, and relevance to humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Fundamentals of transcription factors and their impact on pancreatic development and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

An evaluation of the criterion “Organ weight” under conditions of growth retardation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

A procedure for developing risk-based reference doses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Serum perfluorooctanoic acid and hepatic enzymes, lipoproteins, and cholesterol: A study of occupationally exposed men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

A comparative toxicological investigation of perfluorocarboxylic acids in rats by fluorine-19 NMR spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Animal toxicity studies with ammonium perfluorooctanoate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Uncertainty in toxicological risk assessment for non-carcinogenic health effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Dermal toxicity of ammonium perfluorooctanoate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Inhalation toxicity of ammonium perfluorooctanoate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

The toxicology of perfluorooctanoate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Sex hormone-regulated renal transport of perfluorooctanoic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Lack of evidence for perfluorodecanoyl- or perfluorooctanoyl-coenzyme A formation in male and female rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Molecular epidemiology of pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

The direct effect of hepatic peroxisome proliferators on rat Leydig cell function in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Effect of the peroxisome proliferator, ammonium perfluorooctanoate (C8), on hepatic aromatase activity in adult male Crl:CD BR (CD) rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Genetic abnormalities in pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Comparison of the toxicokinetics between perfluorocarboxylic acids with different carbon chain length

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Plasma cholecystokinin and hepatic enzymes, cholesterol and lipoproteins in ammonium perfluorooctanoate production workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle, Washington

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Genetic alterations in pancreatic carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

The embryo-fetal toxicity and teratogenic potential of ammonium perfluorooctanoate (APFO) in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Health status of plant workers exposed to fluorochemicals--a preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Emerging cellular and molecular themes in pancreatic cancer research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

Disposition of perfluorooctanoic acid in the rat after single and subchronic administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.003

10.1016/J.YRTPH.2004.03.003

7 January 2021

Identifiers

DOI

1 reference

7 December 2017

1 reference